Catalio Capital Management, LP
CIK: 0001958125Latest portfolio: $565.8M · Q4 2025
Holdings
45
Total Value
$565.8M
New Positions
14
Closed Positions
7
Top Holdings
View All 45 Holdings →| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | GILDGILEAD SCIENCES INC | 289,312 | $35.5M | 6.28% | NEW | |
| 2 | BMYBRISTOL-MYERS SQUIBB CO | 647,899 | $34.9M | 6.18% | NEW | |
| 3 | BSXBOSTON SCIENTIFIC CORP | 360,428 | $34.4M | 6.07% | +97K | |
| 4 | BBOTBRIDGEBIO ONCOLOGY THERAPEUT | 410,700 | $31.4M | 5.55% | NEW | |
| 5 | LLYELI LILLY & CO | 25,923 | $27.9M | 4.92% | -31,453 | |
| 6 | DNTHDIANTHUS THERAPEUTICS INC | 653,572 | $26.9M | 4.76% | -14,043 | |
| 7 | ASNDASCENDIS PHARMA A/S | 119,265 | $25.4M | 4.49% | -25,689 | |
| 8 | SNDXSYNDAX PHARMACEUTICALS INC | 1,196,807 | $25.1M | 4.44% | -417,910 | |
| 9 | JNJJOHNSON & JOHNSON | 120,840 | $25.0M | 4.42% | NEW | |
| 10 | REGNREGENERON PHARMACEUTICALS | 29,797 | $23.0M | 4.06% | -5,547 | |
| 11 | GPCRSTRUCTURE THERAPEUTICS INC | 252,901 | $17.6M | 3.11% | -398,909 | |
| 12 | SLNOSOLENO THERAPEUTICS INC | 360,340 | $16.7M | 2.95% | -57,905 | |
| 13 | CYTKCYTOKINETICS INC | 258,381 | $16.4M | 2.90% | -193,200 | |
| 14 | EWEDWARDS LIFESCIENCES CORP | 187,048 | $15.9M | 2.82% | NEW | |
| 15 | ISRGINTUITIVE SURGICAL INC | 27,209 | $15.4M | 2.72% | -44,134 | |
| 16 | NTRANATERA INC | 62,273 | $14.3M | 2.52% | -86,096 | |
| 17 | ADPTADAPTIVE BIOTECHNOLOGIES COR | 821,195 | $13.3M | 2.36% | -63,695 | |
| 18 | ABVXABIVAX SA | 98,514 | $13.3M | 2.35% | -63,627 | |
| 19 | SUPNSUPERNUS PHARMACEUTICALS INC | 257,465 | $12.8M | 2.26% | -29,625 | |
| 20 | GUTSFRACTYL HEALTH INC | 5,491,866 | $12.1M | 2.14% | +278K | |
| 21 | MLYSMINERALYS THERAPEUTICS INC | 331,849 | $12.0M | 2.13% | NEW | |
| 22 | PHATPHATHOM PHARMACEUTICALS INC | 698,996 | $11.6M | 2.05% | -429,525 | |
| 23 | ADMAADMA BIOLOGICS INC | 564,461 | $10.3M | 1.82% | -120,047 | |
| 24 | ACLXARCELLX INC | 156,109 | $10.2M | 1.80% | NEW | |
| 25 | DYNDYNE THERAPEUTICS INC | 519,715 | $10.2M | 1.80% | NEW |
Quarterly Changes
New Positions
Increased Positions
Sector Breakdown
Healthcare100.0% ($3.551034947343663e+191T)
Filing History
Fund Information
Catalio Capital Management, LP is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $565.8M across 45 holdings. The largest position is GILEAD SCIENCES INC (GILD), representing 6.3% of the portfolio. Compared to the previous quarter, the fund opened 14 new positions and closed 7 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.